These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28132699)

  • 1. Substance use and sociodemographic background as risk factors for lifetime psychotic experiences in a non-clinical sample.
    Rognli EB; Bramness JG; Skurtveit S; Bukten A
    J Subst Abuse Treat; 2017 Mar; 74():42-47. PubMed ID: 28132699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An updated and conservative systematic review and meta-analysis of epidemiological evidence on psychotic experiences in children and adults: on the pathway from proneness to persistence to dimensional expression across mental disorders.
    Linscott RJ; van Os J
    Psychol Med; 2013 Jun; 43(6):1133-49. PubMed ID: 22850401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sociodemographic and clinical correlates of psychotic symptoms in the general population: Findings from the MHGP survey.
    Pignon B; Schürhoff F; Szöke A; Geoffroy PA; Jardri R; Roelandt JL; Rolland B; Thomas P; Vaiva G; Amad A
    Schizophr Res; 2018 Mar; 193():336-342. PubMed ID: 28689754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing the hypothesis that psychotic illness begins when subthreshold hallucinations combine with delusional ideation.
    Smeets F; Lataster T; van Winkel R; de Graaf R; Ten Have M; van Os J
    Acta Psychiatr Scand; 2013 Jan; 127(1):34-47. PubMed ID: 22676336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between psychotic experiences and non-accidental self-injury: results from a nationally representative survey of adolescents.
    Hielscher E; Connell M; Lawrence D; Zubrick SR; Hafekost J; Scott JG
    Soc Psychiatry Psychiatr Epidemiol; 2019 Mar; 54(3):321-330. PubMed ID: 30478528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychotic experiences co-occur with sleep problems, negative affect and mental disorders in preadolescence.
    Jeppesen P; Clemmensen L; Munkholm A; Rimvall MK; Rask CU; Jørgensen T; Larsen JT; Petersen L; van Os J; Skovgaard AM
    J Child Psychol Psychiatry; 2015 May; 56(5):558-65. PubMed ID: 25156482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of psychotic symptoms in substance users: a comparison across substances.
    Smith MJ; Thirthalli J; Abdallah AB; Murray RM; Cottler LB
    Compr Psychiatry; 2009; 50(3):245-50. PubMed ID: 19374969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CCC2000 Birth Cohort Study of Register-Based Family History of Mental Disorders and Psychotic Experiences in Offspring.
    Jeppesen P; Larsen JT; Clemmensen L; Munkholm A; Rimvall MK; Rask CU; van Os J; Petersen L; Skovgaard AM
    Schizophr Bull; 2015 Sep; 41(5):1084-94. PubMed ID: 25452427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latent structure of psychosis in the general population: results from the Singapore mental health study.
    Subramaniam M; Abdin E; Vaingankar JA; Verma S; Chong SA
    Psychol Med; 2014 Jan; 44(1):51-60. PubMed ID: 23574702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of anabolic-androgenic steroids and other substances prior to and during imprisonment - Results from the Norwegian Offender Mental Health and Addiction (NorMA) study.
    Havnes IA; Bukten A; Rognli EB; Muller AE
    Drug Alcohol Depend; 2020 Dec; 217():108255. PubMed ID: 32949884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis, schizophrenia genetic risk, and psychotic experiences: a cross-sectional study of 109,308 participants from the UK Biobank.
    Wainberg M; Jacobs GR; di Forti M; Tripathy SJ
    Transl Psychiatry; 2021 Apr; 11(1):211. PubMed ID: 33837184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The associations between psychotic experiences and substance use and substance use disorders: findings from the World Health Organization World Mental Health surveys.
    Degenhardt L; Saha S; Lim CCW; Aguilar-Gaxiola S; Al-Hamzawi A; Alonso J; Andrade LH; Bromet EJ; Bruffaerts R; Caldas-de-Almeida JM; de Girolamo G; Florescu S; Gureje O; Haro JM; Karam EG; Karam G; Kovess-Masfety V; Lee S; Lepine JP; Makanjuola V; Medina-Mora ME; Mneimneh Z; Navarro-Mateu F; Piazza M; Posada-Villa J; Sampson NA; Scott KM; Stagnaro JC; Ten Have M; Kendler KS; Kessler RC; McGrath JJ;
    Addiction; 2018 May; 113(5):924-934. PubMed ID: 29284197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A longitudinal study of adolescent psychotic experiences and later development of substance use disorder and suicidal behavior.
    Cederlöf M; Kuja-Halkola R; Larsson H; Sjölander A; Östberg P; Lundström S; Kelleher I; Lichtenstein P
    Schizophr Res; 2017 Mar; 181():13-16. PubMed ID: 27615409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychotic Experiences in the General Population: A Cross-National Analysis Based on 31,261 Respondents From 18 Countries.
    McGrath JJ; Saha S; Al-Hamzawi A; Alonso J; Bromet EJ; Bruffaerts R; Caldas-de-Almeida JM; Chiu WT; de Jonge P; Fayyad J; Florescu S; Gureje O; Haro JM; Hu C; Kovess-Masfety V; Lepine JP; Lim CC; Mora ME; Navarro-Mateu F; Ochoa S; Sampson N; Scott K; Viana MC; Kessler RC
    JAMA Psychiatry; 2015 Jul; 72(7):697-705. PubMed ID: 26018466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between psychotic symptoms and substance use in young offenders.
    Degenhardt L; Coffey C; Hearps S; Kinner SA; Borschmann R; Moran P; Patton G
    Drug Alcohol Rev; 2015 Nov; 34(6):673-82. PubMed ID: 26084677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence and characteristics of hallucinations, delusions and minor phenomena in a non-demented population sample aged 60 years and over.
    Soulas T; Cleret de Langavant L; Monod V; Fénelon G
    Int J Geriatr Psychiatry; 2016 Dec; 31(12):1322-1328. PubMed ID: 26876683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood Maltreatment and Young Adulthood Hallucinations, Delusional Experiences, and Psychosis: A Longitudinal Study.
    Abajobir AA; Kisely S; Scott JG; Williams G; Clavarino A; Strathearn L; Najman JM
    Schizophr Bull; 2017 Sep; 43(5):1045-1055. PubMed ID: 28338760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher severity of cocaine addiction is associated with tactile and somatic hallucinations.
    Roncero C; Grau-López L; Palma-Álvarez RF; Rodriguez-Cintas L; Ros-Cucurull E; Esojo A; Daigre C
    Eur Psychiatry; 2017 May; 42():63-69. PubMed ID: 28212507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term risk factors for substance-induced and primary psychosis after release from prison. A longitudinal study of substance users.
    Rognli EB; Berge J; Håkansson A; Bramness JG
    Schizophr Res; 2015 Oct; 168(1-2):185-90. PubMed ID: 26359848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does normal developmental expression of psychosis combine with environmental risk to cause persistence of psychosis? A psychosis proneness-persistence model.
    Cougnard A; Marcelis M; Myin-Germeys I; De Graaf R; Vollebergh W; Krabbendam L; Lieb R; Wittchen HU; Henquet C; Spauwen J; Van Os J
    Psychol Med; 2007 Apr; 37(4):513-27. PubMed ID: 17288646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.